• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活动性结节病患者支气管肺泡灌洗中的细胞因子

Cytokines in the bronchoalveolar lavage fluid of patients with active pulmonary sarcoidosis.

作者信息

Girgis R E, Basha M A, Maliarik M, Popovich J, Iannuzzi M C

机构信息

Department of Internal Medicine, Henry Ford Health Sciences Center, Detroit, Michigan 48202, USA.

出版信息

Am J Respir Crit Care Med. 1995 Jul;152(1):71-5. doi: 10.1164/ajrccm.152.1.7599865.

DOI:10.1164/ajrccm.152.1.7599865
PMID:7599865
Abstract

Numerous cytokines are thought to be important in the pathogenesis of granulomatous inflammation and subsequent fibrosis in sarcoidosis. Interleukin (IL)-6 and IL-8, two recently described cytokines with a broad spectrum of proinflammatory effects, could participate in this disease. We obtained bronchoalveolar lavage fluid (BALF) from 16 subjects (13 African-American, three Caucasian) with untreated active pulmonary sarcoidosis and 10 healthy nonsmoking volunteers (nine Caucasian, one African-American). Concentrated BALF was analyzed by an ELISA for IL-6, IL-8, and albumin. The median IL-6 level was 9.8 pg/mg albumin (range, 0-278) for the sarcoid group compared with 0.14 pg/mg (range, 0.14-9.8) in the control subjects (p = 0.001). The corresponding values for IL-8 were 202 pg/mg (range, 35-2179) versus 5.0 pg/mg (range, 0-44) in the control subjects (p < 0.001). Among the sarcoid patients, BALF IL-6 and IL-8 levels correlated with each other (r = 0.96, p < 0.001), and both cytokines correlated with the BALF neutrophil percentage (r = 0.96 and 0.95, respectively; p < 0.001 for both). No difference was detected in IL-8 concentrations as measured by ELISA in culture supernatants of alveolar macrophages obtained from five sarcoid patients and five control subjects. We conclude that IL-6 and IL-8 are elevated in BALF of patients with active sarcoidosis and may be important modulators of the disease process.

摘要

许多细胞因子被认为在结节病的肉芽肿性炎症及随后的纤维化发病机制中起重要作用。白细胞介素(IL)-6和IL-8是最近描述的两种具有广泛促炎作用的细胞因子,可能参与此病。我们从16例未经治疗的活动性肺结节病患者(13例非裔美国人,3例白种人)和10名健康非吸烟志愿者(9例白种人,1例非裔美国人)获取支气管肺泡灌洗液(BALF)。采用酶联免疫吸附测定(ELISA)法分析浓缩BALF中的IL-6、IL-8和白蛋白。结节病组IL-6的中位数水平为9.8 pg/mg白蛋白(范围0 - 278),而对照组为0.14 pg/mg(范围0.14 - 9.8)(p = 0.001)。IL-8的相应值在结节病组为202 pg/mg(范围35 - 2179),对照组为5.0 pg/mg(范围0 - 44)(p < 0.001)。在结节病患者中,BALF中IL-6和IL-8水平相互相关(r = 0.96,p < 0.001),且两种细胞因子均与BALF中性粒细胞百分比相关(分别为r = 0.96和0.95;两者p均< 0.001)。通过ELISA检测,从5例结节病患者和5例对照者获取的肺泡巨噬细胞培养上清液中的IL-8浓度未发现差异。我们得出结论,活动性结节病患者的BALF中IL-6和IL-8升高,可能是疾病进程的重要调节因子。

相似文献

1
Cytokines in the bronchoalveolar lavage fluid of patients with active pulmonary sarcoidosis.活动性结节病患者支气管肺泡灌洗中的细胞因子
Am J Respir Crit Care Med. 1995 Jul;152(1):71-5. doi: 10.1164/ajrccm.152.1.7599865.
2
[Markers of fibrosis and inflammation in exhaled breath condensate (EBC) and bronchoalveolar lavage fluid (BALF) of patients with pulmonary sarcoidosis -- a pilot study].[结节病患者呼出气冷凝液(EBC)和支气管肺泡灌洗液(BALF)中纤维化和炎症标志物——一项初步研究]
Pneumonol Alergol Pol. 2010;78(5):356-62.
3
Upregulation of Th1 cytokine profile (IL-12, IL-18) in bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis.结节病患者支气管肺泡灌洗液中Th1细胞因子谱(IL-12、IL-18)上调。
J Interferon Cytokine Res. 2006 Jun;26(6):400-5. doi: 10.1089/jir.2006.26.400.
4
Priming of alveolar macrophages for interleukin-8 production in patients with idiopathic pulmonary fibrosis.特发性肺纤维化患者肺泡巨噬细胞产生白细胞介素-8的启动作用。
Am J Respir Crit Care Med. 1995 Nov;152(5 Pt 1):1579-86. doi: 10.1164/ajrccm.152.5.7582298.
5
Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis.特发性肺纤维化和结节病患者支气管肺泡灌洗液中白细胞介素-8和单核细胞趋化蛋白-1升高。
Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):655-9. doi: 10.1164/ajrccm.149.3.8118632.
6
Increased levels of interleukin-12 and interleukin-18 in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis.结节病患者支气管肺泡灌洗液中白细胞介素-12和白细胞介素-18水平升高。
J Physiol Pharmacol. 2008 Dec;59 Suppl 6:507-13.
7
Can circulating interleukin-18 differentiate between sarcoidosis and idiopathic pulmonary fibrosis?循环白细胞介素-18 能否区分结节病和特发性肺纤维化?
Scand J Clin Lab Invest. 2011 Nov;71(7):593-7. doi: 10.3109/00365513.2011.597871. Epub 2011 Aug 11.
8
Protein profiles of bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.结节病患者支气管肺泡灌洗 fluid 的蛋白质谱。 (原英文中“fluid”前面似乎少了个“lave”,推测完整应为“bronchoalveolar lavage fluid”即“支气管肺泡灌洗液体” )
Am J Respir Crit Care Med. 2006 May 15;173(10):1145-54. doi: 10.1164/rccm.200507-1126OC. Epub 2006 Jan 26.
9
Th1/Th2/Th17‑related cytokines in the bronchoalveolar lavage fluid of patients with sarcoidosis: association with smoking.结节病患者支气管肺泡灌洗液中Th1/Th2/Th17相关细胞因子:与吸烟的关联
Pol Arch Med Wewn. 2012;122(7-8):320-5.
10
Evaluation of bronchoalveolar lavage fluid phospholipids and cytokine release by alveolar macrophages as prognostic markers in sarcoidosis.评估支气管肺泡灌洗液体中的磷脂以及肺泡巨噬细胞释放的细胞因子作为结节病预后标志物的情况。
Respiration. 2003 Jul-Aug;70(4):376-81. doi: 10.1159/000072901.

引用本文的文献

1
Emerging Therapeutic Options for Refractory Pulmonary Sarcoidosis: The Evidence and Proposed Mechanisms of Action.难治性肺结节病的新兴治疗选择:证据及拟议的作用机制
J Clin Med. 2023 Dec 19;13(1):15. doi: 10.3390/jcm13010015.
2
The Role of Oxidative Stress in Sarcoidosis.氧化应激在结节病中的作用。
Int J Mol Sci. 2021 Oct 28;22(21):11712. doi: 10.3390/ijms222111712.
3
Sarcoidosis manifesting during treatment with secukinumab for psoriatic arthritis.在用司库奇尤单抗治疗银屑病关节炎期间出现的结节病。
BMJ Case Rep. 2021 Feb 22;14(2):e240615. doi: 10.1136/bcr-2020-240615.
4
Emerging Molecular Targets for the Treatment of Refractory Sarcoidosis.治疗难治性结节病的新兴分子靶点
Front Med (Lausanne). 2020 Nov 24;7:594133. doi: 10.3389/fmed.2020.594133. eCollection 2020.
5
Novel protein pathways in development and progression of pulmonary sarcoidosis.肺结节病发生发展中的新蛋白通路。
Sci Rep. 2020 Aug 6;10(1):13282. doi: 10.1038/s41598-020-69281-8.
6
Refractory Sarcoidosis: A Review.难治性结节病:综述
Ther Clin Risk Manag. 2020 Apr 17;16:323-345. doi: 10.2147/TCRM.S192922. eCollection 2020.
7
Psychological burden associated with worse clinical outcomes in sarcoidosis.结节病患者的心理负担与更差的临床结局相关。
BMJ Open Respir Res. 2019 Sep 13;6(1):e000467. doi: 10.1136/bmjresp-2019-000467. eCollection 2019.
8
Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents.托珠单抗用于对类固醇节省疗法和抗TNF药物治疗无效的结节病患者。
Respir Med X. 2019;1. doi: 10.1016/j.yrmex.2019.100004. Epub 2019 Feb 21.
9
Sarcoidosis and Systemic Sclerosis: Strange Bedfellows.结节病与系统性硬化症:奇怪的组合。
Case Rep Rheumatol. 2017;2017:7851652. doi: 10.1155/2017/7851652. Epub 2017 Aug 24.
10
Hyaline-Vascular Type Castleman's Disease, Sarcoidosis, and Crohns Disease.透明血管型卡斯尔曼病、结节病和克罗恩病。
Indian J Hematol Blood Transfus. 2016 Jun;32(Suppl 1):335-9. doi: 10.1007/s12288-015-0580-8. Epub 2015 Sep 1.